Announcements Trials
Browse Landscape

Status

Completed 190Recruiting 130Terminated 86Active not recruiting 71Unknown 69Withdrawn 22Not yet recruiting 16Enrolling by invitation 4Suspended 2Available 2Approved for marketing 2

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 6Pancreatic Neoplasms 4Ovarian Neoplasms 4Sarcoma 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Melanoma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Urologic Neoplasms 1Thyroid Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Chordoma 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Brain Neoplasms 1

Interventions

dodecyl maltoside 1Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Carcinoma, Transitional Cell × Genitourinary × Clear all
NCT06443944 2026-04-14

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

CG Oncology, Inc.

Available
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT05494411 2025-02-28

Named Patient Program for Mitomycin for Pyelocalyceal Solution

UroGen Pharma Ltd.

Available
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡